VML HEALTH

Modern oncology is brilliant but broken. That’s the view of our CEO, Claire Gillis, who points to widening equity gaps in cancer care that demonstrate that we are not making the most of advances in medicine. So how do we fix it? We need to get together, get to the heart of it, and get creative. To find out how (and why) we can do cancer differently, check out our thoughts here: https://lnkd.in/gArRdv5S #VMLHealth #VML #Oncology #HealthcareMarketing #PharmaMarketing #Healthcare #Pharma #CancerCare

“Last month, a friend asked me the impossible question: Of course, they knew the obvious – there’s never a good time to have breast cancer. But they’d seen lots of recent headlines about advances in treatment and naturally assumed it would mean better outcomes for anyone being diagnosed today.” Claire Gillis, VML Health CEO, asks the big question about breast cancer, sharing three reasons to temper expectations. Read more via The Drum: https://lnkd.in/gYwQZWUp #VMLHealth #BreastCancer #BreastCancerAwarenessMonth #MetastaticBreastCancer #MBC #Cancer #Oncology #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma

We are witnessing an important shift in cancer communications — pharma is breathing life into cancer comms. ESMO - European Society for Medical Oncology’s flagship annual congress took place last month in Barcelona, once again laying down new markers of hope for the future of oncology. Susanne Bobadilla, PhD and a team of 15 VML Health and medical, digital strategists and client engagement experts from across the company gave PM LIVE a scoop of the top at the top trends from ESMO 2024 – find out what they mean for the future of cancer care. https://lnkd.in/g9BTsqVu #VMLHealth #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma #Oncology #ESMO #MedicalScience

Is it better to have been diagnosed with breast cancer this year rather than last? Claire Gillis, VML Health CEO, asks the big question about breast cancer, focusing on medical advancements and where comms can help pick up the slack. Read more via The Drum: https://lnkd.in/gYwQZWUp #VMLHealth #BreastCancer #BreastCancerAwarenessMonth #MetastaticBreastCancer #MBC #Cancer #Oncology #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma

It’s been an encouraging year for developments in metastatic breast cancer (mBC), with a host of scientific advances and new treatment options offering hope to patients. As we move beyond #MBCAwarenessDay, here are six big headlines from 2024 from Claire Gillis, Jason Gloye, Nichole Davies, Susanne Bobadilla, PhD, Sarah-Jane Barker and Alexandra Lewis. #1. Pembrolizumab followed by chemotherapy improves overall survival in patients with advanced triple-negative breast cancer. #2. Trastuzumab deruxtecan (Enhertu) offers better progression-free survival and response rates for some metastatic HER2-low and -ultralow breast cancers. #3. Abemaciclib improves progression-free survival in metastatic hormone-receptor-positive, HER2-negative breast cancer. #4. Inavolisib awarded Breakthrough Therapy Designation for PIK3CA-Mutated, HR+/HER2-negative mBC. #5. Triple combination of inavolisib, palbociclib and fulvestrant could reduce the risk of progression or death in patients with PIK3CA-mutant HR+/HER2-negative mBC. #6. Oral selective oestrogen receptor degraders (SERDs) could transform treatment of hormone receptor-positive advanced breast cancer. For a full run-down of all these developments, and many more from 2024, click here: https://lnkd.in/gJRu2jKH #VMLHealth #BreastCancerAwarenessMonth #MetastaticBreastCancer #MBC #BreastCancer #Cancer #Oncology #HealthcareMarketing #Healthcare #PharmaMarketing #Pharma

Delighted to celebrate with our partners AstraZeneca on a MM+M silver award for It’s Time To Rescue Rescue campaign. This winning visual aid challenges PCPs, pulmonologists and allergists to rescue this underperforming category by displaying asthma attack data and depicting the unpredictable rise in inflammation in a graphic format. HCPs gained an understanding of the limitations of albuterol-only rescue, with 71% of specialists agreeing that asthma patients need more. https://lnkd.in/gsaWEmUr #VMLHealth #HealthcareMarketing #PharmaMarketing #Healthcare #Pharma

When you are immunocompromised, everyday can feel like a balancing act. We’re proud to win two Golds and one Silver for "The Balancing Act" at the LIA - London International Awards with our clients at AstraZeneca. This work aims to raise awareness among healthcare professionals of their patients’ hidden struggles. #LIA #LIA2024 #VMLHealth #HealthcareMarketing #PharmaMarketing #Healthcare #Pharma

1 in 3 people living with metastatic breast cancer do not know what type of breast cancer they have. Today, on Metastatic Breast Cancer Awareness Day, ABC Global Alliance in partnership with AstraZeneca highlight findings of a global survey that asked patients critical questions to understand the challenges they face in learning about a diagnosis with metastatic breast cancer and its associated biomarkers. To learn more 👉 https://shorturl.at/axeyI #mBC #metastaticawarenessday #breastcancerawarenessmonth Biomarkers explained 👇

Today is World Metastatic Breast Cancer Day. #MetastaticBreastCancer may be incurable disease, but it’s also a liveable disease. People with mBC have much to offer, lives to live, and memories still to make. Yet, speak to any mBC patient and they’ll tell you the disease is a death sentence in so many more ways than it needs be. Over the next week we will be sharing some of our insights from working with patients over the years. #breastcancerawarnessmonth #mBC #patientsmatter

Check out this beautiful work from the wider VML team for Breast Cancer Awareness Month. VML Brazil’s newest campaign with the Instituto Avon encourages people to both care for breast health and value the opinions of medical specialists. The work will be broadcast in several Latin American countries, including Argentina, Colombia, Chile, Peru and Ecuador. https://lnkd.in/gk-nv_ZS #VML #BreastCancerAwarenessMonth #BreastCancer